Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 124,020 $ 113,915
Accounts receivable 8,314 7,758
Short-term investments (certificates of deposit) 37,002 36,002
Cash deposits with clearing organizations 1,041 1,041
Receivables from broker-dealers and clearing organizations 8,464 7,395
Forgivable loans receivable 1,534 1,616
Securities owned, at fair value 4,278 1,985
Inventory 222 171
Other receivables - related party 944 618
Prepaid expenses and other current assets 14,338 12,680
Total current assets 200,157 183,181
Property and equipment, net 12,278 9,513
Restricted cash 17,387 17,387
Long-term investments, at fair value 1,272 1,390
Intangible assets 14,400 15,223
Goodwill 18,645 18,645
Other assets 936 611
Total assets 265,075 245,950
Current liabilities    
Accounts payable and accrued expenses 44,725 36,127
Accounts payable and accrued expenses - related party 124 222
Accrued commissions and payroll payable 10,713 10,065
Deferred clearing and marketing credits 733 786
Securities sold, not yet purchased, at fair value 0 151
Warrants issued - National 6,671 5,597
Interest payable 332 315
Interest payable - related party 657 669
Notes payable, short-term (net of debt discount of $0 and $973 at March 31, 2018 and December 31, 2017, respectively) 0 8,528
Subsidiary convertible note, short-term, at fair value 12,651 4,700
Deferred revenue 690 0
Derivative warrant liability 78 87
Other current liabilities 1,952 181
Total current liabilities 79,326 67,428
Notes payable, long-term (net of debt discount of $1,047 and $62 at March 31, 2018 and December 31, 2017, respectively) 73,444 43,222
Subsidiary convertible note, long-term, at fair value 0 10,059
Other long-term liabilities 4,759 4,739
Total liabilities 157,529 125,448
Stockholders' equity    
Preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares 1,000,000 shares issued and outstanding as of March 31, 2018 and December 31, 2017; liquidation value of $25.00 per share 1 1
Common stock, $.001 par value, 100,000,000 shares authorized, 52,686,537 and 50,991,285 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively 52 51
Common stock issuable, 104,958 and 158,015 shares as of March 31, 2018 and December 31, 2017, respectively 489 500
Additional paid-in-capital 374,254 364,148
Accumulated deficit (333,145) (312,127)
Total stockholders' equity attributed to the Company 41,651 52,573
Non-controlling interests 65,895 67,929
Total stockholders' equity 107,546 120,502
Total liabilities and stockholders' equity $ 265,075 $ 245,950